Altered sodium channel-protein associations in critical illness myopathy

Por Kraner, Susan D, Novak, Kevin R, Wang, Qingbo, Peng, Junmin, Rich, Mark M
Publicado em 2012

Sodium channel slow inactivation as a therapeutic target for myotonia congenita

Por Novak, Kevin R, Norman, Jennifer, Mitchell, Jacob R, Pinter, Martin J, Rich, Mark M
Publicado no Ann Neurol (2015)

Like mother, like daughter: heritability of female Richardson’s ground squirrel Urocitellus richardsonii cortisol stress responses

Por Bairos-Novak, Kevin R, Ryan, Calen P, Freeman, Angela R, Anderson, W Gary, Hare, James F
Publicado no Curr Zool (2018)

Trust thy neighbour in times of trouble: background risk alters how tadpoles release and respond to disturbance cues

Por Bairos-Novak, Kevin R., Mitchell, Matthew D., Crane, Adam L., Chivers, Douglas P., Ferrari, Maud C. O.
Publicado no Proc Biol Sci (2017)

Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats

Por Novak, Kevin R., Nardelli, Paul, Cope, Tim C., Filatov, Gregory, Glass, Jonathan D., Khan, Jaffar, Rich, Mark M.
Publicado em 2009

Upregulation of the Ca(V) 1.1-ryanodine receptor complex in a rat model of critical illness myopathy

Por Kraner, Susan D., Wang, Qingbo, Novak, Kevin R., Cheng, Dongmei, Cool, David R., Peng, Junmin, Rich, Mark M.
Publicado em 2011

Open-label trial of ranolazine for the treatment of myotonia congenita

Por Arnold, W. David, Kline, David, Sanderson, Alan, Hawash, Ahmed A., Bartlett, Amy, Novak, Kevin R., Rich, Mark M., Kissel, John T.
Publicado no Neurology (2017)